BridgeMD
New treatment option for Relapsing Remitting Multiple Sclerosis (RRMS)
Official title Indole-3-PROpionic Acid Clinical Trials - Multiple Sclerosis
ClinicalTrials.gov ID: NCT07318129
What this study is testing
- What it's testing
- This study, iPROACT-MS, is part of the iPROACT group of clinical trials aiming to investigate the effects of oral supplementation with indole-3-propionic acid (IPA) in humans. IPA is naturally produced as a gut bacterial metabolite with the amino acid tryptophan as substrate.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Women and men ≥18 and ≤65 years of age
- Diagnosed with RRMS according to the 2017 McDonald criteria (or newer updates)
- Routinely treated and monitored for MS
- Speak and read Danish
- Deemed physically and mentally able to participate in this study
You likely can't join if
- Active malignancy
- Diagnosis of Crohn's disease and ulcerative colitis
- Other comorbidities deemed to be relevant
- Haematopoietic stem cell transplantation
- Current or past treatment with non-MS related treatments deemed to be relevant
- Pregnancy or lactation
See the full eligibility criteria
- Women and men ≥18 and ≤65 years of age
- Diagnosed with RRMS according to the 2017 McDonald criteria (or newer updates)
- Routinely treated and monitored for MS
- Speak and read Danish
- Deemed physically and mentally able to participate in this study
- Active malignancy
- Diagnosis of Crohn's disease and ulcerative colitis
- Other comorbidities deemed to be relevant
- Haematopoietic stem cell transplantation
- Current or past treatment with non-MS related treatments deemed to be relevant
- Pregnancy or lactation
- People with MR contraindications:
- Severe claustrophobia
- Incompatible implants/ foreign objects, including implanted pacemakers, heart valve prostheses, prostheses in the middle ear, implanted devices (e.g., insulin pump), metal debris, e.g., metal splinters in the eyes...
The study team makes the final eligibility decision.
Where it's taking place
- Glostrup Municipality, Denmark
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Glostrup Municipality, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.